SION - Sionna Therapeutics Inc.

38.11
-0.240   -0.630%

Share volume: 518,006
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations: -0.11%

PREVIOUS CLOSE
CHG
CHG%
$38.35
-0.24
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
41%
Profitability 35%
Dept financing 19%
Liquidity 50%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-10.62%
1 Month
2.78%
3 Months
-10.54%
6 Months
-0.57%
1 Year
213.92%
2 Year
52.44%
Key data
Stock price
$38.11
P/E Ratio 
N/A
DAY RANGE
$35.10 - $38.61
EPS 
$408.12
52 WEEK RANGE
$10.96 - $46.46
52 WEEK CHANGE
$216.53
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
44.998 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$530,081
AVERAGE 30 VOLUME 
$460,425
Company detail
CEO: Michael Cloonan
Region: US
Website: www.sionnatx.com
Employees: 35
IPO year: 2025
Issue type:
Market: NASDAQ
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients. Our principal executive offices are located in Waltham, MA.

Recent news